CRDL
NASDAQ · Pharmaceuticals
Cardiol Therapeutics Inc-A
$1.42
+0.06 (+4.41%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,609.9% upside
Low Target
$16.80
Average Target
$24.28
High Target
$33.59
Current Price
$1.42
Current
$1.42
$1.42
Target
$24.28
$24.28
$16.80
$24.28 avg
$33.59
Scenario Analysis
Bear Case
$16.80
1,083.1%
Low target
Base Case
$24.28
+1,609.9%
Avg target
Bull Case
$33.59
+2,265.5%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$2.33
-39.1% from high
52-Week Low
$1.23
+15.9% from low
Target vs 52W High
$24.28
+942.1% vs high
Peer Consensus — Pharmaceuticals
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| LLY | Strong Buy | 38 | 79% | $1,330.33 | +12.2% |
| RDY | Strong Sell | 45 | 31% | — | +0.0% |
| JNJ | Buy | 31 | 71% | $299.55 | +15.5% |
| MRK | Buy | 36 | 69% | $159.27 | +23.9% |
| PFE | Hold | 36 | 39% | $33.90 | +26.7% |
| BMY | Hold | 35 | 40% | $174.50 | +169.6% |
| RPRX | Strong Buy | 16 | 88% | $36.26 | -36.1% |
| ZTS | Hold | 24 | 54% | $209.87 | +188.8% |